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Abstract 
Methicillin resistant Staphylococcus aureus (MRSA) is a source of hospital required infection (HAI) world-wide 
and an important human pathogen that is found in most communities in Nigeria. The study was carried out to 
determine the prevalence and resistance pattern of methicillin-resistant strains of Staphylococcus aureus in 
specimens of pus, wound, aspirates and swabs obtained from patients attending the University of Benin Hospital, 
Benin City. A total of 3612 samples collected by clinical staff and sent for routine examination were 
bacteriologically processed using standard methods. Sensitivity tests were carried out by the disc diffusion 
method and minimum inhibitory concentration (MIC) was determined with graded concentrations of oxacillin in 
Mueller-Hinton agar. A total of 3,533 (97.2%) isolates were obtained of which 1315 (37.2%) were 
Staphylococcus aureus. Methicillin-resistant stains of the Staphylococcus aureus isolates were 1039 (79%). 
MRSA was isolated at a significantly higher (p<0.05) rate from pus and wounds of women than men. All the 
MRSA were resistant to ampicillin (100%), 99.8% to streptomycin and 99.9% to tetracycline. Resistance to 
amoxycillin-clavulanate (28.6%) was significantly lower (p<0.001) compared to other agents except for 
vancomycin resistance (0.007%). Therefore, the use of antimicrobial agents other than vancomycin can be 
successful after sensitivity tests have been carefully carried out. The need to improve on the public health 
awareness of the use of antimicrobial agents is further encouraged as this would reduce the incidence and 
prevalence of resistance among clinical isolates especially MRSA. 
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1.0:Introduction 
  Staphylococcus aureus is a commensal and major pathogen of human . The bacterium is important in 
human infections ranging from minor skin-infections to serious life threatening infections that may include 
endocarditis, deep seated abscesses, septicaemia, catheter-associated bacteremia, ventilator-associated 
pneumonia, food borne-illness, toxic shock syndrome (TSS) and many other infections(Chambers,2001). Studies 
in Nigeria have shown that Staphylococcus aureus is the commonest micro-organism isolated from many 
wounds and pus samples (Ako-Nai et al.,1995;Emele and Izomoh,1999).  
 Infections caused by multi-resistant strains of Staphylococcus aureus are identified by their resistance to 
methicillin or oxacillin (MRSA/ORSA). MRSA by definition is any strain of Staphylococcus aureus that has 
developed resistance to beta-lactam antibiotics which include beta-lactam stable formulations such as methicillin, 
oxacillin, flucloxacillin, nafcillin and cephalosporins. These MRSA strains are often responsible for several 
difficult to treat infections in humans (Lowry,2003; Taiwo et al., 2004;Shittu and Lin,2006). MRSA strains have 
also been reported to be implicated in causing progressively increased mortality, morbidity and increased heath 
care costs (French, 1996; Cosgrove et al., 2003;Tiwari et al., 2008).  
 Multi-drug resistant strains of Staphylococcus aureus or MRSA are characteristically resistant to three 
or more classes of antimicrobial agents other than beta-lactams. These stains have been recognized as the most 
common pathogen identified in wound infections (Bell and Jounidge, 2002). Infections caused by 
Staphylococcus aureus have a poorer prognosis when the strain is MRSA (Cosgrove et al., 2003;Tiwari et al., 
2008). MRSA was first recognized in the hospital in 1961(Jevons,1961), but the strain is now increasing 
recognized in the community(Chambers,2001). The prevalence of MRSA varies within countries and in hospitals. 
The prevalence is constantly increasing in many countries and in some hospitals more than half of all 
Staphylococcus aureus isolates are MRSA (Voss,2006). In Nigeria, a prevalence of MRSA that varies between 
34.7% and 71.2% has been reported( Taiwo et al., 2004; Onanuga et al.,2005). The current prevalence of MRSA 
is not precisely known especially in Benin City. The study was carried out to determine the prevalence, and 
resistance pattern of MRSA isolates in pus, wound and swab samples.  
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2.0  Materials and Methods 
2.1 Sample Collection: A total of 3612 clinical samples of pus, wounds, aspirates and discharge swabs collected 
for routine investigation in different wards and clinics of the University of Benin Teaching Hospital, Benin City, 
Nigeria were transported to the laboratory for examination. The specimens were processed within one hour of 
collection. 2.2:  Incubation of Samples: Samples were inoculated onto two blood agar plates (Oxoid CM 55) and 
one incubated anaerobically. Also inoculated were MacConkey agar (Oxoid CM 7) sabouraud dextrose slants 
(Oxoid CM 81), mannitol salt agar (Oxoid CM 85), heated blood agar (Oxoid CM 55) was also inoculated for 
genital swabs. All inoculated media were incubated in air at 37 
0
C, and examined after 18 h. Cultures without or 
insufficient growth were re-incubated for a further 18 h while the cooked meat medium was sub-cultured onto 
two blood agar plates and MacConkey agar for incubation to recover micro-organisms that may have been very 
scanty in  the original specimen.  
2.3. Identification and antibiogram of microbial isolates:Discrete colonies were picked up for characterization 
and identification tests using the scheme outlined (Cowan and Steel, 1974). Sensitivity tests were set up by the 
disc diffusion method (Baker and Beach,1980) in Mueller-Hinton agar (Lab 39). Inoculum size was standardized 
by matching the organisms emulsion in physiological with 0.5 McFarland (BSAC,2009) and the following 
antimicrobial agents discs from Abtek Biologicals (Liverpool, U.K.) were placed 25 mm apart from each other: 
ampicillin 10 µg, amoxycillin-clavulanate 30 µg, cloxacillin  5 µg, oxacillin 1µg, cefuroxime 30µg, ceftazidime 
30 µg,  cefotaxime 30 µg, ofloxacin 5 µg, ciprofloxacin 5 µg, gentamycin 10 µg, streptomycin 10 µg, 
azithromycin 15 µg, erythromycin 5 µg and tetracycline 10 µg. Staphylococcus aureus isolates were 
identified by Gram stain, calalase test, slide and tube coagulase tests, growth in salt and fermentation of mannitol 
and phosphatase production. Oxacillin was diluted in 2 % sodium chloride in concentrations ranging from 0.2-
128 µg/ml in 20 ml of molten Mueller-Hinton agar. An 18 h culture in Mueller-Hinton broth of each 
Staphylococcus aureus isolate was in diluted sterile physiological saline and turbidity adjusted until it matched 
0.5 McFarland standard of 10
4 
cfu/ml. Each plate was inoculated at discrete points with a sterile swab stick and 
incubated at 37 
0
C for 18 h. Oxacillin resistance was recorded when the minimum concentration that inhibited an 
isolate was > 2 µg/ml. Resistance to vancomycin was determined in serial dilutions of vancomycin (1, 
2….32µg/ml) in Mueller-Hinton agar. An 18 h Mueller-Hinton broth culture of each isolate was adjusted to 10
4
 
cfu/ml. MacFarland 0.5 standard. This was spot inoculated and incubated at 37 
o
C for 18 h. Susceptibility 
breakpoints were recorded according to CLSI guidelines(CLSI,2006). 
 Data analysis was done using Chi- Square X
2
  and the degree of confidence was set at 95% (p<0.05) 
3.0:Results 
Examination of 3612 pus, wounds and swab samples resulted in isolation of 3533 (97.2%) significant microbial 
growth. Staphylococcus aureus 1315(37.2%) was the most frequently isolated micro-organisms as shown in Fig. 
1, Klebsiella species, Pseudomonas aeruginosa and other micro-organisms isolated were each less than a third of 
the proportion of Staphylococcus aureus (37.2%)  rate of isolation. 
3.1. Antibiogram of Staphylococcus aureus : The resistance pattern of Staphylococcus aureus isolates to 
antimicrobial agents is shown in Table 1. Of the 1315 Staphylococcus aureus, 1039(79%) were methicillin 
resistant (MRSA). The lowest resistance ratio of 28.6% was with amoxycillin-clavulanate and the highest rates 
of 100%, 99.9% and 99.8% were recorded with ampicillin, streptomycin and tetracycline respectively. The 
resistance of the Staphylococcus aureus varied with other antimicrobial agents.  
 The distribution of MRSA in sample according to gender is shown in Table 2. A significantly higher 
(P<0.05) number of pus, wounds and aspirates from female sources (44.1%) yielded MRSA. MRSA isolates 
from the ear, nose and throat of females were also higher (39.9%) in comparison to 27.9% from males. There 
was no significant difference (p > 0.05) in the isolation rates of MRSA from genital and eye swabs from both 
sexes.  
The resistance pattern of MRSA is presented in Table 3. A total of 868 (83.5%) MRSA isolates were 
resistant to three or more antimicrobial agents. Twenty-nine (2.8%) were resistant to all antimicrobial agent 
except vancomycin and amoxycillin-clavulanate. Resistance to all antimicrobial agents except vancomycin was 
recorded in 29 (2.8%) of the MRSA isolates.  
Vancomycin MIC for 2(0.002%) of MRSA isolates were 4 and 8µg/ml respectively (or vancomycin 
intermediate resistant Staphylococcus aureus, VISA) and 5(0.005%) of the isolates had MIC that ranged from 16 
to 64µg/ml (vancomycin resistant Staphylococcus aureus, VRSA) 
 
 
4.0: Discussion 
This study has revealed that Staphylococcus aureus is the most predominant micro-organism from pus, wounds 
and swab samples as earlier studies have indicated (Bells and Jounldge,2002). The resistance of Staphylococcus 
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aureus to many groups of antimicrobial agents represents a serious concern in therapeutic option available to the 
clinician in managing such infections. Methicillin resistance - the marker of multi-drug resistance showed a high 
MRSA prevalence (79%) amongst isolates of Staphylococcus aureus. Previous study in Nigerian women 
recorded 71.2% (Onanuga et al.,2005). The higher rate from this study is not unexpected because it has been 
reported that MRSA prevalence is ever increasing (Voss, 2006).  
 The lowest resistance of 28.6% was observed with amoxycillin-clavulanate. This may suggest that this 
agent remains important in the management of MRSA in this community. The occurrence of MRSA within the 
genders indicated that females are at a significantly higher (p < 0.05) risk of harbouring or being infected with 
MRSA strains in pus, wounds and ENT samples. The exact reason for this disparity in MRSA isolation is not 
clearly known. It is however, possible that the dressing style of females that encourages more flowing garments 
may facilitate contamination and transference of MRSA to skin breaches or open wounds. The rates of MRSA 
isolation from genital and eye swabs was not significantly different (p > 0.05) in both sexes. 
 MRSA isolates were resistant to three or more groups of antimicrobial in 83.5% of the cases. The 
misuse and misapplication of many antimicrobial agents in many parts of Nigeria may contribute to the high 
MRSA  rate in this community. This poses a significant difficulty in antimicrobial agent choice for patients with 
this variety of infections. The third generation cephalosporins, quinolones and improved macrolides indicated for 
serious infections may have substantially lost their place in treatment of many MRSA infections in this 
community. This indirectly may increase costs of treatment and the additional difficulty in control (Tiwari et al., 
2008).  
5.0: Conclusion:  Resistance to vancomycin - a reserved drug for MRSA observed in this study highlights the 
magnitude of the burden of MRSA in this community. A renewed effort must therefore be put in place at control 
measures that should include a renewed awareness, isolation of MRSA infected patients in hospitals and multi-
drug resistance surveillance and enforcement of empiric use of antimicrobial agents to stem the tide of MRSA.  
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Fig 1: Microorganisms isolated from clinical samples.  
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Table 1: Resistance pattern of Staphylococcus aureus isolates to antimicrobial 
agents  
 
Antimicrobial agent s Resistance (%) 
Amplicillin 1315 (100%) 
Amoxycillin-clavulanate 376 (28.6%) 
Cloxacillin  1044 (79.4%) 
Oxacillin 1039 (79.0%) 
Cefuroxime 575 (43.7%) 
Ceftazidime 714 (54.3%) 
Cefotaxime  546 (41.5%) 
Ofloxacin 558 (42.4%) 
Ciprofloxacin 796 (60.5%) 
Gentamycin 696 (52.9%) 
Streptomycin 1312 (99.8%) 
Azithromycin 601(45.7%) 
Erythromycin 894 (68.0%) 
Tetracycline 1314 (99.9%) 
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Table 2: Distribution of methicllin resistant Staphylococcus aureus in samples 
according to gender  
 
Nature of specimen   
No. of cases (%) 
Male  Female  
Pus/wounds/aspirates  237/993 (23.9%) 263/597 (44.1%) (p < 0.05) 
Genital  92/357 (25.8%) 236/912 (25.9%) (p > 0.05) 
Ear, nose and throat  66/237 (27.9%) 79/198 (39.9%) (p < 0.05) 
Eye 26/90 (28.9%) 40/149 (26.8%) (p > 0.05) 
 
Table 3: Resistance pattern of MRSA isolates   
Resistance to antimicrobial agents  MRSA (%) 
Three or more non-vancomycin 868 (83.5%) 
All antimicrobial except vancomycin and amoxycillin –clavulanate  29 (2.8%) 
All antimicrobial except vancomycin  29 (2.8%) 
All anti-microbial agents including vancomycin  7 (0.007%) 
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